MyopiaSTABLENCT05466955
Slashing Two-wheeled Accidents by Leveraging Eyecare
A study testing Free eye glasses for un or under-corrected myopia in people with Myopia, run by Queen's University, Belfast at 1 site in Vietnam.
Trial summary
STABLE is a stepped-wedge cluster randomised controlled trial and its primary aim is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among eligible motorcycle drivers in Vietnam as measured under naturalistic driving… Read more about this study
- Who is it for?
- Ages 18 to 23 years
- Conditions the study is for
- Myopia
- What is being tested?
- Free eye glasses for un or under-corrected myopia
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 158 participants
- Where
- 1 siteVietnam
- Study dates
- 22 Sep 2024to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 23 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Students from selected universities will be eligible to participate if they:
- are aged 18 to 23 years
- have at least one year or more years of driving experience
- are the sole user of their motorcycle
- use their motorcycle as their primary means of transport
- drive at least 25 km per week (self-report)
Show all 11Show fewer
- hold a valid driving license if their motorcycle has an engine capacity >50cc
- Participants will be eligible for assignment to transition into the intervention group if, during the STABLE clinical examination, they are found to have:
- presenting distance visual acuity <= 6/12 in the better-seeing eye due to un- or under-corrected myopia,
- vision correctable to 6/7.5 or better in both eyes
- at least 0.5 Dioptre of myopia
Who cannot join
- Individuals with any ocular or systemic abnormalities affecting vision will be ineligible to participate.
Trial locations and contacts
1 site in 1 country.
Vietnam1 site
University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Hong Bang Ward 11, 217
About this study
Official title: Slashing Two-wheeled Accidents by Leveraging Eyecare: a Stepped-wedge Cluster Randomised Controlled Trial to Assess Impact of Spectacles on Reducing Crash and Near-crash Events Among Myopic Motorcycle Drivers in Ho Chi Minh City Vietnam
STABLE is a stepped-wedge cluster randomised controlled trial and its primary aim is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among eligible motorcycle drivers in Vietnam as measured under naturalistic driving conditions with the Data Acquisition System (DAS).
STABLE is designed to assess the impact of vision correction on the safety of road users in a a Low and Middle income countries (LMIC) setting. A positive trial outcome would demonstrate the safety benefits of vision correction and would create pressure for tighter regulation of drivers' vision and the promotion of vision correction.
Read more
The study will be conducted in the peri-urban universities in Ho Chi Minh City, Vietnam and 625 students from five universities will be recruited into the trial.
Before conducting the main trial, a pilot of 35 students will be recruited to test DAS and build CNC dictionary.
Duration of the trial is 33 months from enrolment to completion of primary analysis, with 18 months for data collection.
Study participants can be both male and female motorcycle drivers aged 18 to 23 years years with at least one year of driving experience; they must use their motorcycle as their primary means of transport; drive at least 25 km per week and present with un- or under-corrected myopia that can be corrected with spectacles.
Participants with any ocular or systemic abnormality affecting vision, other than un-or under-corrected myopia will be excluded from the trial.
STABLE's primary outcome is CNC events per 1,000 km driven the DAS mounted to the motorcycles of trial participants. An interim analysis of the primary outcome will take place 9 months after data collection begins. The interim analysis will be reviewed by the trial's Data Monitoring and Ethics Committee. Unless a change is needed because of this review, the trial's primary analysis will take place 18 months after the DAS units are fitted to participants' motorcycle).
Compliance with study glasses; self-reported visual function (driving-adapted Visual Function Questionnaire-25 [VFQ-25]); Dula Dangerous Driving Index (DDDI), for all crashes; self-reported CNC events for comparison with recorded CNC events and total delivery cost per CNC event avoided with the intervention (indicator of cost-effectiveness).
Read the detailed description
The primary aim of STABLE is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among young motorcycle drivers in Vietnam.
Road traffic crashes kill more people aged 5 to 29 years worldwide than any other cause and are predicted to become the 7th leading global causes of death for all ages by 2030. The Southeast Asia has among the world's highest burdens of traffic mortality, with 20.7 fatalities per 100,000 population. The United Nations reports that motorcycles account for 93.3% of all motorized vehicles on the road in Vietnam, the highest number as a proportion of all motorized vehicles of any Association of Southeast Asian Nations country.
The investigators recently published a meta-analysis in Lancet Global Health which revealed that drivers with poor vision in Low and Middle-Income Countries (LMICs) had a 46% greater risk of experiencing a road traffic crash than those with good vision Risk Ratio (RR) 1·46, 95% Confidence Interval 1·20 to 1·78, p<0·001, 13 studies). Nevertheless, the impact of poor vision on the safety of young road users in LMICs, where many drivers do not undergo vision testing, remains poorly understood. There is a particular dearth of information for adolescent drivers, who are at greatest risk for crash-related death and the lack of reliable data has proven a significant barrier to inference of cause and effect.
Trials with robust measurement of CNC events with appropriate equipment under conditions of naturalistic driving are needed, and these have become possible only recently, due in part to falling costs and aggressive miniaturisation of GPS and on-board video systems.
STABLE will be the first cluster randomised controlled trial to investigate whether there is a link between vision correction with glasses and road safety in a LMIC.
Rationale for Intervention: The intervention in STABLE is the provision of glasses for the correction of presenting distance visual acuity <= 6/12 in the better-seeing eye due to un- or under-corrected myopia following an eye examination. The intervention will be applied to male and female motorcycle users between ages 18 and 23 enrolled at universities in Ho Chi Minh City, Vietnam
Rationale for Comparator The comparator in STABLE is standard eyecare. For university students in Vietnam, this requires the individual to pay for eyecare services provided by trained ophthalmologists or optometrists and access to good-quality eyecare services amongst university students is low. This is illustrated by the high proportion either not wearing glasses, or having glasses with incorrect power in the unpublished study noted above.
STABLE is an investigator-masked mixed-methods naturalistic driving study using a stepped-wedge cluster randomised trial (SW-CRT) design. It uses a SW-CRT design because, in a conventional parallel group cluster randomised trial, half the clusters would be randomly assigned to the intervention condition and half to the control condition. This approach would necessitate identifying participants with un- or under-corrected myopia and withholding glasses from them if they were randomly assigned to the control group until after the completion of the trial. The STABLE investigators maintain that it would be unethical to withhold glasses from motorcycle drivers who have been identified as needing them through the trial's processes for this length of time. Therefore, working with local stakeholders in Vietnam they agreed on the use of the SW-CRT design, which balances the need to conduct a randomised evaluation of the intervention with the ethical demand to provide glasses to trial participants as soon as their need for vision correction is identified.
Primary objective: is to provide reliable estimates of the impact that vision correction with glasses has on the number of CNC events in a Low- and Middle-Income Country (LMIC) setting.
Secondary objectives: are to investigate the effects of study interventions on self-reported visual function; self-reported crashes for comparison with DAS recorded crashes, and the total delivery cost per crash event avoided.
Recruitment Methods: The research team will approach the Board of Executives of the five universities and explain the purpose of the study and invite them to join the study. If they agree to participate and depending on their assignment, trial partners Asia Injury Prevention Foundation will work with each university's Department of Student Affairs and/or the Student Unions to announce, advertise and follow up on trial recruitment activities. The trial will be advertised on posters, through email and through fan page of either the Department of Student Affairs or the Student Unions.
Informed consent: to participate in STABLE will be sought from 5,200 students in 5 faculties from each university (a total of 25 clusters), to perform a self-assessment of their vision using the WHO's free smartphone-based screening app, WHOeyes. Data Acquisition System(DAS) units will be fit to the motorcycles of 625 drivers (25 per cluster), with an estimated 250 (40% of those that fail the WHOeye self-assessment) judged to be eligible for vision correction and therefore assigned to the intervention condition over the course of the trial. A 30% dropout is anticipated, yielding complete datasets from 175 trial participants.Those who meet the inclusion criteria for DAS fitting and informed consent will undergo the informed consent procedure. 35 students will be recruited from the university to be involved in the pilot study, and 175 students (35 per cluster) will be recruited from each of the other five universities for the main trial.
Sequence generation: At each sequence (step), a centralised, password-protected web-based system will be used to randomly select five clusters from those that have not yet been assigned to STABLE's intervention group. The PI on site, or an individual with delegated authority, will access the system to generate the list of five randomly selected clusters.
Diversified Technical Systems (DTS) has developed the DAS for STABLE to support the research questions and objectives of the trial. The DAS will be connected to two colour, wide-angle view video cameras: forward-facing and driver-facing. Additional data streams include: 3-axis accelerometer, Geographic Positioning System (GPS), braking and ground speed.
DAS will be fitted on site to the motorcycles of eligible students who provide informed consent to participate in the trial. For the pilot study this will take place in the week prior to the start of the pilot study. For the main trial this will take place in the month preceding the start of the trial. It will take approximately 7 days to complete DAS fitting at each university, and approximately 35 days to fit the DAS to the motorcycles of all 625 participants.
Data collection and study Instruments: Trial data collection instruments will be used to capture the outcome measures. Data collection from DAS will begin after each DAS unit has been installed on the motorcycles of consenting participants. In the main trial, the first eye examination will take place 12 weeks after the last DAS unit is fitted. After the first eye examination DAS data will only be collected from those who:
- are in a cluster that has not yet been randomly selected for transition from the control period, or
- have undergone an eye examination and been diagnosed with uncorrected myopia or under-corrected myopia (and thereby entered the intervention group) The DAS systems will be removed from the motorcycles of those participants who have had an eye examination and do not meet the inclusion criteria for assignment to the intervention group. This process will be repeated at each sequence, until DAS data are being collected from only those who meet the inclusion criteria for assignment to the intervention group (myopes only). DAS data will be collected from these DAS units up until the time they are removed from the motorcycles. Data collection from all 35 clusters will cease after the final 5 clusters in the sequence have completed 12 weeks of follow up.
During the first three transitions, DAS units will be removed from students not entering intervention conditions, while their data are retained for secular trend modelling. In the final two transitions, DAS units will remain to continue collecting non-intervention driving data, strengthening secular trend assessment within the stepped-wedge design.
Prospective participants will be contacted by email and Short Messaging Service and asked to complete a screening questionnaire to know their age, ownership of bike.
Participants who meet the inclusion criteria for DAS fitting and informed consent will be contacted again and asked to provide the following information by questionnaire:
Data Collection
- KoboToolbox
- CRF 1 - Eligibility for Informed Consent and DAS Fitting
- CRF 2 - Baseline Assessment (VFQ 25, Dula Dangerous Driving Index)
- CRF 3 Part 1 - Before DAS Fitting
- CRF 3 Part 2 - After DAS Fitting
- CRF 5 - Vision Function Follow-up Assessment
- CRF 6 - USB Swap
- CRF 7 - Crash Report 19
- MACRO
- CRF 4 - Vision Examination
- Protocol Deviation Form
- Adverse Event Form
- Serious Adverse Event Form
- Off Study Form
- PI Sign Off Form Data will be collected using a mix of electronic and paper Case Report Forms (CRF).
Data capture by AIPF will be facilitated via KoboToolbox. Data capture by NICTU will be facilitated via MACRO.
Assessments in the event of a crash: Crash and Injury Self-Report Questionnaire (CI SRQ) will be collected from each participant involved in a crash event that results in hospitalisation. During the main trial, research assistants will maintain contact with participants by Short Messaging Service (SMS) on a twice monthly basis to retrieve DAS data and ensure that they are motivated to continue with the study.
Statistical Methods: Baseline demographic and clinical characteristics will be reported for all participants who are eligible for the intervention group for whom the data is available. Baseline characteristics will be summarised by means and standard deviations, medians and inter-quartile ranges, or numbers and percentages as appropriate.
Analysis of the primary outcome will use the mixed effects Poisson regression model. If the outcome includes a large number of zero values, a zero-inflated mixed effects Poisson model will be applied. In the presence of overdispersion, we will use a zero-inflated mixed effects negative binomial model. If any of these models fail to converge, a linear mixed effects model will be used as an alternative.
Null hypotheses and analyses for secondary outcomes take a similar form to that for the primary outcome. Mean differences for continuous outcomes and risk differences for binary outcomes will be reported (all adjusting for cluster, secular and time effects).
An agreement analysis will be done to compare VFQ-25 total scores at baseline and four weeks after receiving spectacles. Assuming that the response will be from the same participant and the time will be fixed, we will use the ICC and the concordance correlation coefficient (CCC) to estimate the agreement between the baseline and four weeks results.
- Conditions
- Myopia
- Being tested
- Free eye glasses for un or under-corrected myopia
- Keywords
- crash events, near-crash events, myopia, motorcycle drivers
- Medical subject headings
- Myopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Free eye glasses for un or under-corrected myopiaDevice
All participants randomised to the intervention group will be provided with free eye glasses
| Study group | Role | What they receive |
|---|---|---|
| Free eye glasses for un or under-corrected myopia | Experimental | Free eyeglasses for the correction of uncorrected myopia will be provided to participants at the time of enrolment into the intervention group. Receives: Device: Free eye glasses for un or under-corrected myopia |
| Control-No treatment | No intervention | Participants in the control period will not have glasses but the SW-CRT design means that all trial participants with uncorrected myopia will receive free glasses by the trials' completion, and no participant will have glasses withheld after being diagnosed with un- or under-corrected myopia. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Crash and near-crash (CNC) events per 1,000 km driven
CNC events as measured by Global Positioning System (GPS) and a gyroscopic sensor-video data-acquisition system (DAS) mounted to the motorcycles of trial participants.
Measured: up to18 months
Secondary outcomes (4)
Cost-effectiveness
Total delivery cost per CNC event avoided with the intervention is the indicator of cost-effectiveness
Measured: 18 months, Collected at the end of the trial.
Self-reported crashes
self- reported crashes compared with Data Aquisition System reported crashes and injuries are assessed using the questionnaire (Crash and Injury Self-Report Questionnaire [CI SRQ]).
Measured: up to 18 months
Spectacle compliance
Glasses wear compliance will be assessed throughout the trial using a driver-facing camera mounted on the motorcycle's handlebars.
Measured: up to 18 months
Visual Function
Visual Function is assessed by self-reported visual function (driving-adapted Visual Function Questionnaire-25 [VFQ-25]).
Measured: VFQ-25 is administered at baseline and one month after receiving glasses.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2022
- Study start22 Sep 2024
- Primary completionOct 2026 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (59)Papers the sponsor has linked to this study.
- Other trials for MyopiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- STABLE is a naturalistic driving trial with a Stepped Wedge-Cluster Randomised Trial (SW-CRT) design. The unit of randomisation in STABLE is the cluster: five universities in Ho Chi Minh City, Vietnam. The design involves random, sequential crossover of clusters from control to intervention until all clusters are exposed to the study intervention. The stepped-wedge cohort design with exchangeable correlation structure will comprise six sequences (steps) of an estimated seven myopic participants per cluster, and five clusters per sequence. The duration of each sequence is 12 weeks. Participants will not be masked to whether they are in the control or intervention period but investigators assessing study outcomes will be masked to this.
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 158 participants (actual)
Sponsor and investigators
- Lead sponsor
- Queen's University, Belfast
- Sponsor type
- University, hospital or other
- Collaborators
- L.V. Prasad Eye Institute, University of Medicine and Pharmacy at Ho Chi Minh City, Asia Injury Prevention Foundation, Clearly, Belfast Health and Social Care Trust, Transport Development and Strategy Institute, Ministry of Transport, Vietnam, Eye Care Foundation, Ho Chi Minh City, Vietnam
- Responsible party
- Principal investigator, Nathan Congdon, Queen's University, Belfast
- Investigators
- Tô Gia Kiên, PhD, Principal investigator, University of Medicine and Pharmacy at Ho Chi Minh City Vietnam
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05466955
- Sponsor's protocol ID
- MHLS 22_68
- Acronym
- STABLE
- Status last verified
- Aug 2026
- First submitted
- 11 Jul 2022
- Last updated
- 13 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All Individual Participant Data (IPD) will be stored in anonymised format. The IPD that includes personal identifiable information will be deleted when the data collection process is complete and before the initiation of data analysis. Only de-identified data will be shared with all the researchers for analysis.The primary analysis will be conducted on all outcome data obtained from all enrolled participants as randomised.
Publications
Peden M, Oyegbite K, Ozanne-Smith J, Hyder AA, Branche C, Rahman AKMF, Rivara F, Bartolomeos K, editors. World Report on Child Injury Prevention. Geneva: World Health Organization; 2008. Available from http://www.ncbi.nlm.nih.gov/books/NBK310641/
PubMed 26269872Dolgin E. The myopia boom. Nature. 2015 Mar 19;519(7543):276-8. doi: 10.1038/519276a. No abstract available.
PubMed 25788077Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.
PubMed 28951126Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.
PubMed 26875007Paudel P, Ramson P, Naduvilath T, Wilson D, Phuong HT, Ho SM, Giap NV. Prevalence of vision impairment and refractive error in school children in Ba Ria - Vung Tau province, Vietnam. Clin Exp Ophthalmol. 2014 Apr;42(3):217-26. doi: 10.1111/ceo.12273. Epub 2014 Jan 28.
PubMed 24299145Limburg H, Gilbert C, Hon DN, Dung NC, Hoang TH. Prevalence and causes of blindness in children in Vietnam. Ophthalmology. 2012 Feb;119(2):355-61. doi: 10.1016/j.ophtha.2011.07.037. Epub 2011 Oct 27.
PubMed 22035577Ma X, Zhou Z, Yi H, Pang X, Shi Y, Chen Q, Meltzer ME, le Cessie S, He M, Rozelle S, Liu Y, Congdon N. Effect of providing free glasses on children's educational outcomes in China: cluster randomized controlled trial. BMJ. 2014 Sep 23;349:g5740. doi: 10.1136/bmj.g5740.
PubMed 25249453Wang X, Yi H, Lu L, Zhang L, Ma X, Jin L, Zhang H, Naidoo KS, Minto H, Zou H, Rozelle S, Congdon N. Population Prevalence of Need for Spectacles and Spectacle Ownership Among Urban Migrant Children in Eastern China. JAMA Ophthalmol. 2015 Dec;133(12):1399-406. doi: 10.1001/jamaophthalmol.2015.3513.
PubMed 26426113Piyasena P, Olvera-Herrera VO, Chan VF, Clarke M, Wright DM, MacKenzie G, Virgili G, Congdon N. Vision impairment and traffic safety outcomes in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Health. 2021 Oct;9(10):e1411-e1422. doi: 10.1016/S2214-109X(21)00303-X. Epub 2021 Aug 16.
PubMed 34411516Pepple G, Adio A. Visual function of drivers and its relationship to road traffic accidents in Urban Africa. Springerplus. 2014 Jan 24;3:47. doi: 10.1186/2193-1801-3-47. eCollection 2014.
PubMed 24505558Swain TA, McGwin G Jr, Wood JM, Antin JF, Owsley C. Naturalistic Driving Techniques and Association of Visual Risk Factors With At-Fault Crashes and Near Crashes by Older Drivers With Vision Impairment. JAMA Ophthalmol. 2021 Jun 1;139(6):639-645. doi: 10.1001/jamaophthalmol.2021.0862.
PubMed 33914022Hanowski RJ, Hickman JS, Olson RL, Bocanegra J. Evaluating the 2003 revised hours-of-service regulations for truck drivers: the impact of time-on-task on critical incident risk. Accid Anal Prev. 2009 Mar;41(2):268-75. doi: 10.1016/j.aap.2008.11.007. Epub 2008 Dec 25.
PubMed 19245885Simons-Morton BG, Gershon P, O'Brien F, Gensler G, Klauer SG, Ehsani JP, Zhu C, Gore-Langton RE, Dingus TA. Crash rates over time among younger and older drivers in the SHRP 2 naturalistic driving study. J Safety Res. 2020 Jun;73:245-251. doi: 10.1016/j.jsr.2020.03.001. Epub 2020 Apr 8.
PubMed 32563399Klauer SG, Guo F, Simons-Morton BG, Ouimet MC, Lee SE, Dingus TA. Distracted driving and risk of road crashes among novice and experienced drivers. N Engl J Med. 2014 Jan 2;370(1):54-9. doi: 10.1056/NEJMsa1204142.
PubMed 24382065Guo F, Klauer SG, Fang Y, Hankey JM, Antin JF, Perez MA, Lee SE, Dingus TA. The effects of age on crash risk associated with driver distraction. Int J Epidemiol. 2017 Feb 1;46(1):258-265. doi: 10.1093/ije/dyw234.
PubMed 28338711
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Slashing Two-wheeled Accidents by Leveraging Eyecare: a Stepped-wedge Cluster Randomised Controlled Trial to Assess Impact of Spectacles on Reducing Crash and Near-crash Events Among Myopic Motorcycle Drivers in Ho Chi Minh City Vietnam
- ClinicalTrials.gov ID
- NCT05466955
- Acronym / sponsor ID
- STABLE / MHLS 22_68
- Conditions
- Myopia
- Keywords
- crash events, near-crash events, myopia, motorcycle drivers
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 158 participants (actual)
- Lead sponsor
- Queen's University, BelfastUniversity, hospital or other
- Collaborators
- L.V. Prasad Eye Institute, University of Medicine and Pharmacy at Ho Chi Minh City, Asia Injury Prevention Foundation, Clearly, Belfast Health and Social Care Trust, Transport Development and Strategy Institute, Ministry of Transport, Vietnam, Eye Care Foundation, Ho Chi Minh City, Vietnam
- Study start
- 22 Sep 2024 (actual)
- Primary completion
- Oct 2026 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 20 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
STABLE is a stepped-wedge cluster randomised controlled trial and its primary aim is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among eligible motorcycle drivers in Vietnam as measured under naturalistic driving conditions with the Data Acquisition System (DAS).
STABLE is designed to assess the impact of vision correction on the safety of road users in a a Low and Middle income countries (LMIC) setting. A positive trial outcome would demonstrate the safety benefits of vision correction and would create pressure for tighter regulation of drivers' vision and the promotion of vision correction.
The study will be conducted in the peri-urban universities in Ho Chi Minh City, Vietnam and 625 students from five universities will be recruited into the trial.
Before conducting the main trial, a pilot of 35 students will be recruited to test DAS and build CNC dictionary.
Duration of the trial is 33 months from enrolment to completion of primary analysis, with 18 months for data collection.
Study participants can be both male and female motorcycle drivers aged 18 to 23 years years with at least one year of driving experience; they must use their motorcycle as their primary means of transport; drive at least 25 km per week and present with un- or under-corrected myopia that can be corrected with spectacles.
Participants with any ocular or systemic abnormality affecting vision, other than un-or under-corrected myopia will be excluded from the trial.
STABLE's primary outcome is CNC events per 1,000 km driven the DAS mounted to the motorcycles of trial participants. An interim analysis of the primary outcome will take place 9 months after data collection begins. The interim analysis will be reviewed by the trial's Data Monitoring and Ethics Committee. Unless a change is needed because of this review, the trial's primary analysis will take place 18 months after the DAS units are fitted to participants' motorcycle).
Compliance with study glasses; self-reported visual function (driving-adapted Visual Function Questionnaire-25 [VFQ-25]); Dula Dangerous Driving Index (DDDI), for all crashes; self-reported CNC events for comparison with recorded CNC events and total delivery cost per CNC event avoided with the intervention (indicator of cost-effectiveness).
Detailed description
The primary aim of STABLE is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among young motorcycle drivers in Vietnam.
Road traffic crashes kill more people aged 5 to 29 years worldwide than any other cause and are predicted to become the 7th leading global causes of death for all ages by 2030. The Southeast Asia has among the world's highest burdens of traffic mortality, with 20.7 fatalities per 100,000 population. The United Nations reports that motorcycles account for 93.3% of all motorized vehicles on the road in Vietnam, the highest number as a proportion of all motorized vehicles of any Association of Southeast Asian Nations country.
The investigators recently published a meta-analysis in Lancet Global Health which revealed that drivers with poor vision in Low and Middle-Income Countries (LMICs) had a 46% greater risk of experiencing a road traffic crash than those with good vision Risk Ratio (RR) 1·46, 95% Confidence Interval 1·20 to 1·78, p<0·001, 13 studies). Nevertheless, the impact of poor vision on the safety of young road users in LMICs, where many drivers do not undergo vision testing, remains poorly understood. There is a particular dearth of information for adolescent drivers, who are at greatest risk for crash-related death and the lack of reliable data has proven a significant barrier to inference of cause and effect.
Trials with robust measurement of CNC events with appropriate equipment under conditions of naturalistic driving are needed, and these have become possible only recently, due in part to falling costs and aggressive miniaturisation of GPS and on-board video systems.
STABLE will be the first cluster randomised controlled trial to investigate whether there is a link between vision correction with glasses and road safety in a LMIC.
Rationale for Intervention: The intervention in STABLE is the provision of glasses for the correction of presenting distance visual acuity <= 6/12 in the better-seeing eye due to un- or under-corrected myopia following an eye examination. The intervention will be applied to male and female motorcycle users between ages 18 and 23 enrolled at universities in Ho Chi Minh City, Vietnam
Rationale for Comparator The comparator in STABLE is standard eyecare. For university students in Vietnam, this requires the individual to pay for eyecare services provided by trained ophthalmologists or optometrists and access to good-quality eyecare services amongst university students is low. This is illustrated by the high proportion either not wearing glasses, or having glasses with incorrect power in the unpublished study noted above.
STABLE is an investigator-masked mixed-methods naturalistic driving study using a stepped-wedge cluster randomised trial (SW-CRT) design. It uses a SW-CRT design because, in a conventional parallel group cluster randomised trial, half the clusters would be randomly assigned to the intervention condition and half to the control condition. This approach would necessitate identifying participants with un- or under-corrected myopia and withholding glasses from them if they were randomly assigned to the control group until after the completion of the trial. The STABLE investigators maintain that it would be unethical to withhold glasses from motorcycle drivers who have been identified as needing them through the trial's processes for this length of time. Therefore, working with local stakeholders in Vietnam they agreed on the use of the SW-CRT design, which balances the need to conduct a randomised evaluation of the intervention with the ethical demand to provide glasses to trial participants as soon as their need for vision correction is identified.
Primary objective: is to provide reliable estimates of the impact that vision correction with glasses has on the number of CNC events in a Low- and Middle-Income Country (LMIC) setting.
Secondary objectives: are to investigate the effects of study interventions on self-reported visual function; self-reported crashes for comparison with DAS recorded crashes, and the total delivery cost per crash event avoided.
Recruitment Methods: The research team will approach the Board of Executives of the five universities and explain the purpose of the study and invite them to join the study. If they agree to participate and depending on their assignment, trial partners Asia Injury Prevention Foundation will work with each university's Department of Student Affairs and/or the Student Unions to announce, advertise and follow up on trial recruitment activities. The trial will be advertised on posters, through email and through fan page of either the Department of Student Affairs or the Student Unions.
Informed consent: to participate in STABLE will be sought from 5,200 students in 5 faculties from each university (a total of 25 clusters), to perform a self-assessment of their vision using the WHO's free smartphone-based screening app, WHOeyes. Data Acquisition System(DAS) units will be fit to the motorcycles of 625 drivers (25 per cluster), with an estimated 250 (40% of those that fail the WHOeye self-assessment) judged to be eligible for vision correction and therefore assigned to the intervention condition over the course of the trial. A 30% dropout is anticipated, yielding complete datasets from 175 trial participants.Those who meet the inclusion criteria for DAS fitting and informed consent will undergo the informed consent procedure. 35 students will be recruited from the university to be involved in the pilot study, and 175 students (35 per cluster) will be recruited from each of the other five universities for the main trial.
Sequence generation: At each sequence (step), a centralised, password-protected web-based system will be used to randomly select five clusters from those that have not yet been assigned to STABLE's intervention group. The PI on site, or an individual with delegated authority, will access the system to generate the list of five randomly selected clusters.
Diversified Technical Systems (DTS) has developed the DAS for STABLE to support the research questions and objectives of the trial. The DAS will be connected to two colour, wide-angle view video cameras: forward-facing and driver-facing. Additional data streams include: 3-axis accelerometer, Geographic Positioning System (GPS), braking and ground speed.
DAS will be fitted on site to the motorcycles of eligible students who provide informed consent to participate in the trial. For the pilot study this will take place in the week prior to the start of the pilot study. For the main trial this will take place in the month preceding the start of the trial. It will take approximately 7 days to complete DAS fitting at each university, and approximately 35 days to fit the DAS to the motorcycles of all 625 participants.
Data collection and study Instruments: Trial data collection instruments will be used to capture the outcome measures. Data collection from DAS will begin after each DAS unit has been installed on the motorcycles of consenting participants. In the main trial, the first eye examination will take place 12 weeks after the last DAS unit is fitted. After the first eye examination DAS data will only be collected from those who:
- are in a cluster that has not yet been randomly selected for transition from the control period, or
- have undergone an eye examination and been diagnosed with uncorrected myopia or under-corrected myopia (and thereby entered the intervention group) The DAS systems will be removed from the motorcycles of those participants who have had an eye examination and do not meet the inclusion criteria for assignment to the intervention group. This process will be repeated at each sequence, until DAS data are being collected from only those who meet the inclusion criteria for assignment to the intervention group (myopes only). DAS data will be collected from these DAS units up until the time they are removed from the motorcycles. Data collection from all 35 clusters will cease after the final 5 clusters in the sequence have completed 12 weeks of follow up.
During the first three transitions, DAS units will be removed from students not entering intervention conditions, while their data are retained for secular trend modelling. In the final two transitions, DAS units will remain to continue collecting non-intervention driving data, strengthening secular trend assessment within the stepped-wedge design.
Prospective participants will be contacted by email and Short Messaging Service and asked to complete a screening questionnaire to know their age, ownership of bike.
Participants who meet the inclusion criteria for DAS fitting and informed consent will be contacted again and asked to provide the following information by questionnaire:
Data Collection
- KoboToolbox
- CRF 1 - Eligibility for Informed Consent and DAS Fitting
- CRF 2 - Baseline Assessment (VFQ 25, Dula Dangerous Driving Index)
- CRF 3 Part 1 - Before DAS Fitting
- CRF 3 Part 2 - After DAS Fitting
- CRF 5 - Vision Function Follow-up Assessment
- CRF 6 - USB Swap
- CRF 7 - Crash Report 19
- MACRO
- CRF 4 - Vision Examination
- Protocol Deviation Form
- Adverse Event Form
- Serious Adverse Event Form
- Off Study Form
- PI Sign Off Form Data will be collected using a mix of electronic and paper Case Report Forms (CRF).
Data capture by AIPF will be facilitated via KoboToolbox. Data capture by NICTU will be facilitated via MACRO.
Assessments in the event of a crash: Crash and Injury Self-Report Questionnaire (CI SRQ) will be collected from each participant involved in a crash event that results in hospitalisation. During the main trial, research assistants will maintain contact with participants by Short Messaging Service (SMS) on a twice monthly basis to retrieve DAS data and ensure that they are motivated to continue with the study.
Statistical Methods: Baseline demographic and clinical characteristics will be reported for all participants who are eligible for the intervention group for whom the data is available. Baseline characteristics will be summarised by means and standard deviations, medians and inter-quartile ranges, or numbers and percentages as appropriate.
Analysis of the primary outcome will use the mixed effects Poisson regression model. If the outcome includes a large number of zero values, a zero-inflated mixed effects Poisson model will be applied. In the presence of overdispersion, we will use a zero-inflated mixed effects negative binomial model. If any of these models fail to converge, a linear mixed effects model will be used as an alternative.
Null hypotheses and analyses for secondary outcomes take a similar form to that for the primary outcome. Mean differences for continuous outcomes and risk differences for binary outcomes will be reported (all adjusting for cluster, secular and time effects).
An agreement analysis will be done to compare VFQ-25 total scores at baseline and four weeks after receiving spectacles. Assuming that the response will be from the same participant and the time will be fixed, we will use the ICC and the concordance correlation coefficient (CCC) to estimate the agreement between the baseline and four weeks results.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (investigator)
- Number of arms
- 2
- Model description
- STABLE is a naturalistic driving trial with a Stepped Wedge-Cluster Randomised Trial (SW-CRT) design. The unit of randomisation in STABLE is the cluster: five universities in Ho Chi Minh City, Vietnam. The design involves random, sequential crossover of clusters from control to intervention until all clusters are exposed to the study intervention. The stepped-wedge cohort design with exchangeable correlation structure will comprise six sequences (steps) of an estimated seven myopic participants per cluster, and five clusters per sequence. The duration of each sequence is 12 weeks. Participants will not be masked to whether they are in the control or intervention period but investigators assessing study outcomes will be masked to this.
| Arm | Type | Receives |
|---|---|---|
| Free eye glasses for un or under-corrected myopia | Experimental | Device: Free eye glasses for un or under-corrected myopiaFree eyeglasses for the correction of uncorrected myopia will be provided to participants at the time of enrolment into the intervention group. |
| Control-No treatment | No intervention | –Participants in the control period will not have glasses but the SW-CRT design means that all trial participants with uncorrected myopia will receive free glasses by the trials' completion, and no participant will have glasses withheld after being diagnosed with un- or under-corrected myopia. |
Who may qualify
- Ages
- 18 to 23 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (11 listed)
- are aged 18 to 23 years
- have at least one year or more years of driving experience
- are the sole user of their motorcycle
- use their motorcycle as their primary means of transport
- drive at least 25 km per week (self-report)
Key exclusion criteria (1 listed)
- Individuals with any ocular or systemic abnormalities affecting vision will be ineligible to participate.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Free eye glasses for un or under-corrected myopiaAll participants randomised to the intervention group will be provided with free eye glasses | Device | Free eye glasses for un or under-corrected myopia |
Primary outcome
Crash and near-crash (CNC) events per 1,000 km driven
Time frame: up to18 months
CNC events as measured by Global Positioning System (GPS) and a gyroscopic sensor-video data-acquisition system (DAS) mounted to the motorcycles of trial participants.
4 secondary outcomes
Cost-effectiveness
Time frame: 18 months, Collected at the end of the trial.
Self-reported crashes
Time frame: up to 18 months
Spectacle compliance
Time frame: up to 18 months
Visual Function
Time frame: VFQ-25 is administered at baseline and one month after receiving glasses.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
- Background: PubMed 26269872Peden M, Oyegbite K, Ozanne-Smith J, Hyder AA, Branche C, Rahman AKMF, Rivara F, Bartolomeos K, editors. World Report on Child Injury Prevention. Geneva: World Health Organization; 2008. Available from http://www.ncbi.nlm.nih.gov/books/NBK310641/
- Background: PubMed 25788077Dolgin E. The myopia boom. Nature. 2015 Mar 19;519(7543):276-8. doi: 10.1038/519276a. No abstract available.
- Background: PubMed 28951126Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.
- Background: PubMed 26875007Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.
- Background: PubMed 24299145Paudel P, Ramson P, Naduvilath T, Wilson D, Phuong HT, Ho SM, Giap NV. Prevalence of vision impairment and refractive error in school children in Ba Ria - Vung Tau province, Vietnam. Clin Exp Ophthalmol. 2014 Apr;42(3):217-26. doi: 10.1111/ceo.12273. Epub 2014 Jan 28.
- Background: PubMed 22035577Limburg H, Gilbert C, Hon DN, Dung NC, Hoang TH. Prevalence and causes of blindness in children in Vietnam. Ophthalmology. 2012 Feb;119(2):355-61. doi: 10.1016/j.ophtha.2011.07.037. Epub 2011 Oct 27.
- Background: PubMed 25249453Ma X, Zhou Z, Yi H, Pang X, Shi Y, Chen Q, Meltzer ME, le Cessie S, He M, Rozelle S, Liu Y, Congdon N. Effect of providing free glasses on children's educational outcomes in China: cluster randomized controlled trial. BMJ. 2014 Sep 23;349:g5740. doi: 10.1136/bmj.g5740.
- Background: PubMed 26426113Wang X, Yi H, Lu L, Zhang L, Ma X, Jin L, Zhang H, Naidoo KS, Minto H, Zou H, Rozelle S, Congdon N. Population Prevalence of Need for Spectacles and Spectacle Ownership Among Urban Migrant Children in Eastern China. JAMA Ophthalmol. 2015 Dec;133(12):1399-406. doi: 10.1001/jamaophthalmol.2015.3513.
- Background: PubMed 34411516Piyasena P, Olvera-Herrera VO, Chan VF, Clarke M, Wright DM, MacKenzie G, Virgili G, Congdon N. Vision impairment and traffic safety outcomes in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Health. 2021 Oct;9(10):e1411-e1422. doi: 10.1016/S2214-109X(21)00303-X. Epub 2021 Aug 16.
- Background: PubMed 24505558Pepple G, Adio A. Visual function of drivers and its relationship to road traffic accidents in Urban Africa. Springerplus. 2014 Jan 24;3:47. doi: 10.1186/2193-1801-3-47. eCollection 2014.
- Background: PubMed 33914022Swain TA, McGwin G Jr, Wood JM, Antin JF, Owsley C. Naturalistic Driving Techniques and Association of Visual Risk Factors With At-Fault Crashes and Near Crashes by Older Drivers With Vision Impairment. JAMA Ophthalmol. 2021 Jun 1;139(6):639-645. doi: 10.1001/jamaophthalmol.2021.0862.
- Background: PubMed 19245885Hanowski RJ, Hickman JS, Olson RL, Bocanegra J. Evaluating the 2003 revised hours-of-service regulations for truck drivers: the impact of time-on-task on critical incident risk. Accid Anal Prev. 2009 Mar;41(2):268-75. doi: 10.1016/j.aap.2008.11.007. Epub 2008 Dec 25.
- Individual participant dataSharing planned: Yes. All Individual Participant Data (IPD) will be stored in anonymised format. The IPD that includes personal identifiable information will be deleted when the data collection process is complete and before the initiation of data analysis. Only de-identified data will be shared with all the researchers for analysis.The primary analysis will be conducted on all outcome data obtained from all enrolled participants as randomised.
Related trials for Myopia
Recruiting
Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial
Pre-myopia, Myopia
Not yet recruiting
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment
Myopia, Myopia Progressing
Not yet recruiting
Clinical Performance and Outcomes After Toric Lens Transition
Astigmatism
Active, not recruiting
Effect of IOP Lowering on Progressive HM
High Myopia, Intraocular Pressure
Recruiting
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Hyperopia and Myopia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tô Gia Kiên, PhD principal investigator
University of Medicine and Pharmacy at Ho Chi Minh City Vietnam
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Free eye glasses for un or under-corrected myopia in people with Myopia, run by Queen's University, Belfast at 1 site in Vietnam.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Crash and near-crash (CNC) events per 1,000 km driven (time frame: up to18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05466955, which also lists 59 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.